← Back to Search

Vaccine

Pfizer/BioNTech (BNT162b2) for COVID-19

Phase 2 & 3

Waitlist Available

Led By Sohail Rao, MD,MA,DPhil

Research Sponsored by DHR Health Institute for Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

Study Summary

This trial will test whether giving a booster dose of the Pfizer/BioNTech and/or Moderna vaccine to people who have already been vaccinated and are at high risk for reinfection will help to prevent infection.

Eligible Conditions

COVID-19
Coronavirus

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Levels of anti-SARS-CoV-2 IgG antibody titers after booster

Number of participants infected with SARS-CoV-2 after booster Dose

Secondary outcome measures

Identify differences in immune responses based on comorbidity status

Measure rate of decline of immune responses

Trial Design

1Treatment groups

Experimental Treatment

Group I: Administration of Booster DoseExperimental Treatment2 Interventions

study participant will receive either 30ug in 0.3 ml of Pfizer/BioNTech (BNT162b2) or 0.25 ml of Moderna vaccine administered intramuscularly.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

DHR Health Institute for Research and DevelopmentLead Sponsor

11 Previous Clinical Trials

3,346 Total Patients Enrolled

1 Trials studying COVID-19

1,500 Patients Enrolled for COVID-19

Sohail Rao, MD,MA,DPhilPrincipal InvestigatorDHR Health Institute for Research and Development

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many research subjects are being enrolled in this study?

"That is correct, the clinical trial is still recruiting patients. Based on the information found on clinicaltrials.gov, the study was first posted on 7/30/2021 and was last updated on 3/14/2022. The study needs to recruit 1000 participants from 4 different locations."

Answered by AI

Are there any participant vacancies in this research project?

"Yes, this trial is currently recruiting patients, as reflected on clinicaltrials.gov. The listing for this study was published on 7/30/2021 and was last updated on 3/14/2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS

Sohail Rao 2021. "PROSPECTIVE OPEN LABEL CLINICAL TRIAL TO ADMINISTER A BOOSTER DOSE OF PFIZER/BIONTECH OR MODERNA COVID-19 VACCINE IN HIGH-RISK INDIVIDUALS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05279365.